13D/13G Filings - Akero Therapeutics Inc. (AKRO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-09-16
10:16 am
Purchase
2022-09-1513GAkero Therapeutics, Inc.
AKRO
Avidity Partners Management LP3,105,000
6.900%
3,105,000increase
(New Position)
Filing
History
2022-09-15
5:00 pm
Sale
2022-09-1313DAkero Therapeutics, Inc.
AKRO
venBio Global Strategic Fund II L.P.714,000
1.900%
-1,601,893decrease
(-69.17%)
Filing
History
2022-06-28
4:19 pm
Purchase
2022-06-1713GAkero Therapeutics, Inc.
AKRO
PFIZER INC
PFE
2,525,252
6.700%
2,525,252increase
(New Position)
Filing
History
2022-02-14
5:07 pm
Sale
2021-12-3113GAkero Therapeutics, Inc.
AKRO
Redmile Group LLC1,602,285
4.600%
-720,272decrease
(-31.01%)
Filing
History
2022-02-14
4:26 pm
Purchase
2021-12-3113GAkero Therapeutics, Inc.
AKRO
Point72 Asset Management, L.P.1,760,248
5.000%
8,685increase
(+0.50%)
Filing
History
2022-02-11
8:25 pm
Purchase
2021-12-3113GAkero Therapeutics, Inc.
AKRO
ALKEON CAPITAL MANAGEMENT LLC2,479,671
7.100%
192,041increase
(+8.39%)
Filing
History
2022-02-11
5:03 pm
Sale
2021-12-3113GAkero Therapeutics, Inc.
AKRO
Atlas Venture Fund XI L.P.1,963,529
5.600%
-242,883decrease
(-11.01%)
Filing
History
2022-02-10
2:07 pm
Sale
2021-12-3113GAkero Therapeutics, Inc.
AKRO
JANUS HENDERSON GROUP PLC
JHG
3,163,622
9.100%
-329,797decrease
(-9.44%)
Filing
History
2022-02-08
4:19 pm
Purchase
2021-12-3113GAkero Therapeutics, Inc.
AKRO
GOLDMAN SACHS GROUP INC
GS
1,776,192
5.100%
1,776,192increase
(New Position)
Filing
History
2022-02-04
4:12 pm
Purchase
2021-12-3113GAkero Therapeutics, Inc.
AKRO
BlackRock Inc.
BLK
1,944,122
5.600%
1,944,122increase
(New Position)
Filing
History
2022-02-04
09:12 am
Purchase
2021-12-3113GAkero Therapeutics, Inc.
AKRO
Wellington Management Group LLP1,876,811
5.380%
1,876,811increase
(New Position)
Filing
History
2021-12-13
4:58 pm
Purchase
2021-12-1013GAkero Therapeutics, Inc.
AKRO
Point72 Asset Management, L.P.1,751,563
5.000%
1,751,563increase
(New Position)
Filing
History
2021-06-30
4:17 pm
Purchase
2021-06-2113GAkero Therapeutics, Inc.
AKRO
Skorpios Trust4,907,829
14.100%
4,907,829increase
(New Position)
Filing
History
2021-06-28
8:56 pm
Sale
2021-06-2113DAkero Therapeutics, Inc.
AKRO
ATP Life Science Ventures L.P.674,640
1.900%
-5,164,229decrease
(-88.45%)
Filing
History
2021-05-07
4:13 pm
Sale
2021-05-0413DAkero Therapeutics, Inc.
AKRO
venBio Global Strategic Fund II L.P.2,315,893
6.650%
-352,824decrease
(-13.22%)
Filing
History
2021-02-16
5:27 pm
Sale
2020-12-3113GAkero Therapeutics, Inc.
AKRO
Atlas Venture Fund XI L.P.2,206,412
6.400%
-500,000decrease
(-18.47%)
Filing
History
2021-02-16
4:05 pm
Purchase
2020-12-3113GAkero Therapeutics, Inc.
AKRO
Redmile Group LLC2,322,557
6.690%
2,322,557increase
(New Position)
Filing
History
2021-02-12
8:41 pm
Sale
2020-12-3113GAkero Therapeutics, Inc.
AKRO
Versant Venture Capital VI L.P.777,727
2.200%
-2,878,858decrease
(-78.73%)
Filing
History
2021-02-11
4:54 pm
Purchase
2020-12-3113GAkero Therapeutics, Inc.
AKRO
ALKEON CAPITAL MANAGEMENT LLC2,287,630
6.600%
2,287,630increase
(New Position)
Filing
History
2021-02-11
3:50 pm
Sale
2020-12-3113GAkero Therapeutics, Inc.
AKRO
JANUS HENDERSON GROUP PLC
JHG
3,493,419
10.100%
-13,809decrease
(-0.39%)
Filing
History
Goto Prev, 0, 1, 2, 3, Next